Rigel Pharmaceuticals Inc Liquidation Value

RIGL Other

Cash & Equivalents

$40.58M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $40.58M
Total Obligations: -$152.75M
$-112.17M
Per share: $-6.13
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $40.58M
AR: $51.76M
Total Obligations: -$152.75M
$-60.40M
Per share: $-3.30
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $40.58M
AR: $51.76M
Inventory: $11.51M
Total Obligations: -$152.75M
$-48.90M
Per share: $-2.67
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-112.17M$-6.13
Liquid Liquidation Value$-60.40M$-3.30
Operating Liquidation Value$-48.90M$-2.67

Key Components (as of 2025-12-31)

Cash & Equivalents$40.58M
Accounts Receivable$51.76M
Inventory$11.51M
Current Liabilities$99.24M
Long-term Debt$52.50M
Op. Lease Liability$1.01M
Finance LeaseN/A
Shares Outstanding18.3M

Explore all 187 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$40.58M$51.76M$11.51M$7.19M$99.24M$52.50M$1.01MN/A
2025-09-30$48.53M$45.92M$13.30M$3.85M$94.40M$60.00M$1.15MN/A
2025-06-30$53.41M$39.91M$10.42M$7.29M$86.64M$60.00M$1.23MN/A
2025-03-31$45.73M$41.55M$4.66M$3.95M$66.63M$60.00M$1.32MN/A
2024-12-31$56.75M$41.62M$6.00M$3.34M$63.30M$60.00M$285,000N/A
2024-09-30$51.69M$30.57M$4.78M$3.81M$54.31M$60.00M$466,000N/A
2024-06-30$36.05M$28.90M$8.06M$6.13M$58.65M$60.00M$639,000N/A
2024-03-31$25.57M$27.51M$6.58M$9.28M$73.20M$60.00M$809,000N/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-03-03 View
2025-09-30 10-Q 2025-11-04 View
2025-06-30 10-Q 2025-08-05 View
2025-03-31 10-Q 2025-05-06 View
2024-12-31 10-K 2025-03-04 View
2024-09-30 10-Q 2024-11-07 View
2024-06-30 10-Q 2024-08-06 View
2024-03-31 10-Q 2024-05-07 View

Community Notes

Loading notes...

Questions

Loading questions...